Send to

Choose Destination
See comment in PubMed Commons below

Biomolecular and Clinical Aspects of Chinese Wolfberry.


In: Benzie IFF, Wachtel-Galor S, editors.


Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2011. Chapter 14.


Although the benefits of wolfberry are well known and highly thought of in TCM, scientific evidence regarding its benefits is unclear. The objective of this review is to highlight the numerous health benefits of wolfberry from a rigorous scientific and clinical perspective. Arguments and evidence are given in this chapter indicating that LBP is not that unique, and that many of the potential benefits are related to indirect evidence (Sze et al. 2008). We also draw attention to new and refreshing initiatives of researchers, such as Chang and So (2008) who are trying to identify new ways to conduct research on wolfberry, for instance, by looking at its effects in relation to preventing neuronal death in neurodegenerative diseases. New ideas regarding the delivery of bioactives from wolfberry, and other TCM herbs in general (Wang et al. 2005), are also a part of this review.

Copyright © 2011 by Taylor and Francis Group, LLC.

PubMed Commons home

PubMed Commons

How to join PubMed Commons
    Support Center